Lessons learned from the use of 1,977 in-situ bilateral internal mammary arteries: a retrospective study by unknown
Mohammadi et al. Journal of Cardiothoracic Surgery 2014, 9:158
http://www.cardiothoracicsurgery.org/content/9/1/158RESEARCH ARTICLE Open AccessLessons learned from the use of 1,977 in-situ
bilateral internal mammary arteries: a retrospective
study
Siamak Mohammadi1, Francois Dagenais1, Pierre Voisine1, Eric Dumont1, Richard Baillot1, Daniel Doyle1,
Eric Charbonneau1 and Dimitri Kalavrouziotis1,2*Abstract
Background: We sought to determine the early and long-term results of in-situ bilateral internal mammary artery
(BIMA) grafting in patients undergoing coronary artery bypass graft surgery (CABG).
Methods: Between 1992 and 2011, 16,364 patients underwent primary isolated CABG involving at least one in-situ
IMA at our institution. Among these, 1,977 patients underwent in-situ BIMA grafting: the right IMA was used to
revascularize the right coronary artery system in 1,279, the circumflex system in 454 patients, and the left anterior
descending (LAD) in 244. Logistic and Cox regression analyses were used to predict in-hospital mortality and
cumulative late death.
Results: Late survival among BIMA patients was negatively and independently influenced by chronic obstructive
pulmonary disease (hazard ratio (HR) 2.4, 95% confidence interval (CI) 1.6-3.4, p = 0.0005), age (HR 1.2, 95% CI 1.1-1.3,
p < 0.001), and mediastinitis (HR 2.1, 95% CI 1.1-4.2, p < 0.03). Gender, body mass index, diabetes, choice of target
for the second (non-LAD) IMA, and conduit grafted to the LAD (RIMA vs. LIMA) did not influence late survival
among BIMA patients. A BIMA grafting strategy was significantly beneficial for younger patients. However, it was
not associated with superior late survival for patients aged 66 years and above at the time of CABG, and showed a
trend to harm among octogenarians (HR 1.05, 95% CI 0.70-1.56, p = 0.80).
Conclusions: Female gender, non-insulin dependent diabetes, and the site of second IMA anastomosis did not
influence early and long-term outcomes in patients undergoing CABG with in-situ BIMA grafting. The right and left
IMAs are equally effective conduits for the LAD. However, advanced age, chronic obstructive pulmonary disease,
and insulin-treated diabetes mellitus have a negative impact on late survival among patients with BIMA grafts.
Keywords: Coronary artery bypass graft surgery, Arterial grafts, OutcomesBackground
Given the superior late patency of the internal mammary
artery (IMA) over venous grafts, it is reasonable to ex-
pect that bilateral internal mammary artery (BIMA)
grafting would translate to enhanced survival following
coronary artery bypass graft surgery (CABG). Numerous
retrospective studies [1-3] have documented superior re-
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article, unless otherwise stated.grafting. However, concerns about perioperative compli-
cations and the technical challenges inherent in BIMA
grafting limit its broad utilization [4]. Our institution
has previously reported that there may exist an age “cut-
off” after which the survival benefit associated with
BIMA grafting is lost [5]. However, limited power and a
relatively short follow-up restricted our ability to identify
the patient subgroups that would derive maximal benefit
from BIMA grafting. Therefore, the objectives of the
present study were two-fold: (1) to evaluate the late sur-
vival of an expanded number of a consecutive, real-world
cohort of patients with BIMA grafting with longer follow-
up and (2) to identify which patient characteristics, if any,entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this




n = 1,977 n = 14,387 p value
Age (mean years ± SD) 55.5 ± 8.6 64.3 ± 9.6 <0.0001
Female 10.9 22.6 <0.0001
Body mass index (mean kg/m2 ± SD) 27.2 ± 3.7 27.9 ± 4.6 <0.0001
Diabetes mellitus 12.3 31.9 <0.0001
Insulin-dependent 2.5 9.7 <0.0001
Renal failure 3.4 7.4 <0.0001
Previous MI 50.5 52.3 0.13
Hypertension 49.3 64.0 <0.0001
Active smoking 32.2 22.0 <0.0001
COPD 6.2 13.1 <0.0001
Peripheral vascular disease 9.0 15.3 <0.0001
Previous stroke 3.1 6.3 <0.0001
LVEF≤ 35% 3.9 6.7 <0.0001
CHF NYHA class III or IV 18.0 26.3 <0.0001
Atrial fibrillation 1.5 3.7 <0.0001
Three-vessel disease 58.7 53.0 <0.0001
Parsonnet score (mean ± SD) 1.4 ± 0.9 2.1 ± 2.2 <0.0001
EuroSCORE (mean ± SD) 1.9 ± 2.7 3.6 ± 4.5 <0.0001
Operative Data
Urgent or emergency 18.5 23.1 <0.0001
Off-pump 2.3 3.2 0.03
Aortic clamp time (mean min ± SD) 57.6 ± 18.2 50.7 ± 18.3 <0.0001
CPB time (mean min ± SD) 82.4 ± 23.8 76.4 ± 23.7 <0.0001
Number of distals (mean ± SD) 3.6 ± 1.0 3.3 ± 1.0 <0.0001
BIMA bilateral internal mammary artery, CPB Cardiopulmonary bypass, CHF
congestive heart failure, COPD chronic obstructive pulmonary disease, IMA
internal mammary artery, LVEF left ventricular ejection fraction, MI myocardial
infarction, NYHA New York Heart Association, SD standard deviation.
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Clinical data were obtained from our computerized car-
diac surgical database which collects information pro-
spectively. Between January 1992 and February 2011,
16,364 consecutive adult patients underwent primary
isolated CABG involving at least one in-situ IMA on the
left anterior descending (LAD) at our institution. Among
them, 1,977 patients with in-situ (proximally connected
to the subclavian artery) BIMA grafts, with or without
other supplemental venous conduits, were identified.
The right IMA was used to revascularize the right cor-
onary artery (RCA) system in 1,279, the circumflex sys-
tem in 454, and the LAD in 244 patients. The left IMA
was used to revascularize the LAD in 1,743, the circum-
flex system in 181, and the diagonal in 53 patients. The
choice of the coronary territory receiving the IMAs was
based on coronary anatomy and surgeon preference. All
patients without a provincial health insurance number
as well as those who had their CABG later in the study
period (after 2009) were excluded from the long-term
analysis. Therefore, long-term data were available for
1,862 patients (94.2%) with BIMA, and was 100%
complete as of November 2009. The date of death was
obtained from provincial vital statistics.
Statistical analysis
Results are expressed as mean ± standard deviation (SD) or
median as appropriate for continuous variables and propor-
tions for categorical variables. Continuous and dichotomous
variables were analysed using one-way ANOVA or Chi-
square tests, respectively. Multivariate logistic regression
was used to determine the predictors of in-hospital mortal-
ity as well as deep sternal wound infection (DSWI). Kaplan-
Meier survival analysis was performed for late all-cause
mortality and Cox proportional hazards multivariate regres-
sion modelling was used to estimate hazard ratios of late
death among BIMA patients. Demographic, pre-, and intra-
operative variables including territory grafted were pre-
sented to the model. Variables with a p < 0.25 on univariate
analysis were candidates for model building. The adequacy
of the proportional hazards assumption was verified using
the graphical representation of the logarithm of the cumu-
lative hazard rates versus time to assess parallelism and
constant separation among the different values of nominal
variables; the continuous variable age was stratified into 4
disjointed strata. Also, an artificially time-dependent covari-
ate was added to the model to test the proportionality as-
sumption. For all variables in the final model, proportional
hazards assumptions were not rejected. Statistical signifi-
cance was present when the two-tailed p value < 0.05.Analyses were performed using SAS version 9.2 (SAS
Institute Inc., Cary, NC).
This study was in accordance with our institutional re-
view board (Quebec Heart and Lung Institute Ethics
Committee). Individual patient consent was waived due
to the observational nature of the study.
Results
Patient characteristics
There were notable differences among BIMA and SIMA
patients, with a significantly lower prevalence of several
relevant risk factors in the former group (Table 1). The
mean number of distal anastomoses was slightly higher
among BIMA patients and aortic clamp and cardiopul-
monary bypass (CPB) times were on average approxi-
mately 6 minutes longer in the BIMA cohort. The clinical
characteristics of BIMA patients were further stratified by
gender, body mass index (BMI), and diabetes (Table 2).
There were 243 patients with diabetes (including 50
Table 2 Baseline characteristics of BIMA patients stratified by gender, body mass index, and diabetes
Variable (% unless
otherwise indicated)
Male Female BMI > 30 BMI ≤ 30 Diabetes no insulin No Diabetes
n = 1,761 n = 216 p value n = 402 n = 1,575 p value n = 193 n = 1,734 p value
Age (mean year ± SD) 55.0 ± 8.1 59.2 ± 11.5 <0.0001 54.3 ± 9.3 55.8 ± 8.4 0.002 57.4 ± 8.7 55.2 ± 8.5 0.0006
Female --- --- --- 11.2 10.9 0.86 9.3 10.8 0.62
BMI (mean kg/m2 ± SD) 27.3 ± 3.7 26.8 ± 4.1 0.09 32.6 ± 2.3 25.9 ± 2.6 <0.0001 28.7 ± 4.1 27.1 ± 3.6 <0.0001
Diabetes 12.2 13.4 0.59 18.7 10.7 <0.0001 --- --- ---
Insulin-dependent 18.5 16.2 0.43 20.6 21.0 1.0 --- --- ---
Renal failure 3.5 2.8 0.84 3.0 3.5 0.76 3.6 3.2 0.67
Previous MI 51.5 45.9 0.06 48.3 51.1 0.34 49.5 51.0 0.08
Hypertension 59.7 69.0 0.01 57.7 47.2 <0.001 65.8 68.9 0.15
Active smoking 32.4 30.7 0.64 29.3 32.4 0.12 28.3 32.5 0.06
COPD 6.4 4.6 0.37 6.0 6.3 0.9 7.3 6.1 0.53
Peripheral vascular disease 8.1 10.2 0.09 6.5 9.6 0.05 11.4 8.0 0.13
Previous stroke 2.9 5.1 0.09 3.2 3.1 0.87 2.6 3.2 0.83
LVEF≤ 35% 3.8 4.8 0.45 3.6 4.0 0.88 4.2 3.6 0.68
CHF NYHA class III or IV 16.8 18.0 0.09 19.9 17.6 0.31 20.5 17.6 0.32
Atrial fibrillation 1.5 1.4 1.00 2.0 1.4 3.37 2.1 1.4 0.56
Three-vessel disease 59.2 54.6 0.21 59.2 58.6 0.86 62.7 58.2 0.25
BIMA bilateral internal mammary artery, CPB Cardiopulmonary bypass, CHF congestive heart failure, COPD chronic obstructive pulmonary disease, IMA internal
mammary artery, LVEF left ventricular ejection fraction, MI myocardial infarction, NYHA New York Heart Association, SD standard deviation.
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betic BIMA patients were on average 2 years older and
had slightly higher BMI than non-diabetic BIMA patients;
all other characteristics seemed to be equally distributed
among diabetic and non-diabetic BIMA patients (Table 2).
Among BIMA patients, there were 402 patients with a
BMI > 30 kg/m2 (mean 32.6 ± 2.3); these patients were
slightly younger than those with BMI ≤ 30 kg/m2 (Table 2).
There were no major differences in the clinical character-
istics of BIMA patients according to which IMA (right vs.
left) was used to revascularize the LAD and the choice of
non-LAD target receiving the second IMA (Table 3).
Early outcomes
In-hospital morbidity and mortality
The in-hospital mortality for the BIMA cohort was 1.0%
(n = 20) compared with 1.8% (n = 264) among the single
IMA patients (p = 0.009)(Table 4). The multivariate pre-
dictors of in-hospital mortality among the entire cohort
of CABG patients with at least one in-situ IMA on the
LAD were: age > 75 years (odds ratio (OR) 2.5, 95% con-
fidence interval (CI) 1.8–3.4, p < 0.0001), female gender
(OR 1.9, 95% CI 1.4–2.5, p < 0.0001), preoperative renal
failure (OR 3.1, 95% CI 2.2–4.3, p < 0.0001), postopera-
tive stroke (OR 4.3, 95% CI 2.7–6.8, p < 0.0001), postop-
erative de-novo renal failure (OR 3.1, 95% CI 2.2–4.2,
p < 0.0001), mechanical ventilation > 48 hours (OR 11.2,
95% CI 8.0–15.6, p < 0.0001), and duration of CPB (OR
1.1, 95% CI 1.01–1.2, p < 0.0001). BIMA was notassociated with in-hospital mortality on multivariate
analysis (p = 0.43). Among BIMA patients, the site of
the second IMA anastomosis to a non-LAD target (p =
0.33), the use of the left versus right IMA to revascularize
the LAD (p = 0.25), female gender (p = 0.47), and DSWI
(p = 0.39) were not associated with in-hospital mortality
on univariate logistic regression.
Deep sternal wound infection
The incidence of DSWI was doubled in the BIMA patients
(2.4% (n = 48) vs. 1.2% (n = 172), p < 0.0001)(Table 4). Dia-
betes was more prevalent among patients who developed
DSWI compared to those who did not have this complica-
tion (37.5% vs. 11.7%, p < 0.0001). Mean age (58.2 ± 8.1 vs.
55.4 ± 8.6, p= 0.02), mean BMI (29.8 ± 4.3 vs. 27.2 ± 3.7, p <
0.0001), mean Parsonnet score (8.0 ± 5.9 vs. 4.9 ± 4.9, p <
0.0001) and the prevalence of chronic obstructive pulmonary
disease (COPD)(14.6% vs. 6.0%, p= 0.02), peripheral vascular
disease (20.8% vs. 8.7%, p= 0.01), and female gender (20.8%
vs. 10.7%, p= 0.03) were higher among BIMA patients who
developed DSWI compared to those who did not. The
multivariate independent predictors of DSWI in the entire
cohort are shown in Table 5. In this model, no statistically
significant effect modification was identified between BIMA
and the other predictors of DSWI.
Long-term survival
The median follow-up of BIMA patients was 8.1 years
(interquartile range, 4.7 to 13 years). During follow-up,
Table 3 Baseline characteristics of BIMA patients stratified by use of left versus right IMA to revascularize the LAD (left
part of table), and by choice of non-LAD target (RCA vs. circumflex) for the second IMA (right part of table)
Variable (% unless
otherwise indicated)
RIMA-LAD LIMA-LAD p value 2nd IMA-Cx 2nd IMA-RCA p value
n = 234 n = 1,743 n = 650 n = 1,239
Age (mean years ± SD) 54.1 ± 8.7 55.6 ± 8.5 0.06 55.8 ± 8.4 55.4 ± 8.5 0.31
Female 10.8 11.0 0.9 10.7 11.1 0.88
BMI (mean kg/m2 ± SD) 27.3 ± 3.8 27.1 ± 3.7 0.83 27.3 ± 3.8 27.2 ± 3.6 0.65
Diabetes mellitus 13.8 12.2 0.49 13.7 12.5 0.52
Insulin-dependent 18.5 21.5 1.0 18.7 22.9 0.51
Renal failure 5.1 3.2 0.15 2.1 3.0 0.07
Previous MI 45.9 51.0 0.2 43.7 47.8 0.24
Hypertension 44.9 50.1 0.18 55.2 56.1 0.19
Active smoking 33.2 32.0 0.74 30.4 33.0 0.29
COPD 5.6 6.2 0.88 6.7 5.6 0.46
Peripheral vascular disease 8.2 8.9 0.79 9.9 8.5 0.34
Previous stroke 2.0 3.3 0.39 2.3 3.6 0.13
LVEF≤ 35% 3.6 3.9 1.0 4.8 3.4 0.15
CHF NYHA class III or IV 19.5 18.0 0.62 15.5 17.3 0.55
Atrial fibrillation 2.6 1.4 0.22 1.5 1.3 0.83
Three-vessel disease 56.1 58.9 0.44 56.8 64.9 0.08
Parsonnet score (mean ± SD) 1.3 ± 0.9 1.4 ± 0.9 0.76 1.4 ± 1.0 1.3 ± 0.9 0.12
EuroSCORE (mean ± SD) 1.6 ± 1.4 1.9 ± 2.8 0.06 2.0 ± 2.9 1.9 ± 2.6 0.44
BIMA bilateral internal mammary artery, CPB Cardiopulmonary bypass, CHF congestive heart failure, COPD chronic obstructive pulmonary disease, IMA internal
mammary artery, LVEF left ventricular ejection fraction, MI myocardial infarction, NYHA New York Heart Association, SD standard deviation.
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with BIMA. BIMA patients with diabetes had signifi-
cantly lower unadjusted survival rates (91.7%, 84.4% and
77.0%) compared to BIMA patients without diabetes at
5, 10, and 15 years (96.0%, 89.8% and 81.5%, log-rank
p = 0.006). However, once insulin-dependent diabetics
were removed from this analysis, there was no longer a
survival disparity between BIMA patients without dia-
betes and those with non-insulin dependent diabetesTable 4 Postoperative adverse events
Outcome (% unless otherwise
indicated)
BIMA Single IMA
n = 1,977 n = 14,387 p value
Mortality 1.0 1.8 0.009
De-novo atrial fibrillation 15.6 23.3 <0.0001
Re-exploration for bleeding 3.7 3.7 0.96
De-novo renal failure* 3.9 7.0 <0.0001
Stroke 0.8 1.7 0.003
Deep sternal wound infection 2.4 1.2 <0.0001
Mechanical ventilation > 48 hours 1.8 2.8 0.01
Blood product transfusion 42.2 48.5 <0.0001
Mean hospital length of stay (days) 5 6 0.01
*Defined as a 50-μmol/L absolute rise in baseline serum creatinine or a new
need for dialysis.
BIMA bilateral internal mammary arteries.(log-rank p = 0.28, Figure 1A). BIMA patients with
DSWI had lower 5-, 10-, and 15-year survival (85.6%,
77.6% and 69.8%) compared to BIMA patients without
this type of infection (95.8%, 89.4% and 81.2%, log-
rank p = 0.0009, Figure 1B). There were no significant
late survival differences among BIMA patients stratified
by BMI (log-rank p = 0.53) and gender (log-rank p = 0.08)
(Figure 1C, D).
When we looked at the non-LAD target of the second
IMA, unadjusted survival rates at 5, 10, and 15 years
were 95.6%, 89.0% and 80.9% for patients with a second
IMA anastomosis to the RCA system, which was not
significantly different compared to those in whom the
second IMA was anastomosed to the circumflex system
(96.0%, 92.1% and 84.0%, log-rank p = 0.2, Figure 2A).
Furthermore, using the left versus the right IMA to
revascularize the LAD had no impact on late survival, al-
though there was a trend toward better survival among
those patients who received LIMA to the LAD (log-rank
p = 0.06, Figure 2B).
The Cox multivariate proportional hazards model iden-
tified age, COPD, and DSWI as the independent predic-
tors of late death among BIMA patients (hazard ratio
(HR) 1.2, 95% CI 1.1-1.3, p < 0.001; HR 2.4, 95% CI 1.6-
3.4, p = 0.0005; and HR 2.1, 95% CI 1.1-4.2, p < 0.03, re-
spectively). The site of the second (non-LAD) IMA
Table 5 Multivariate predictors of deep sternal wound
infection
Variable Odds ratio 95% CI p value
BIMA 3.8 2.6–5.4 <0.0001
Diabetes mellitus 2.2 1.6–2.9 <0.0001




Postoperative delirium 1.6 1.04–2.4 0.03
Postoperative renal failure* 2.2 1.5–3.2 <0.0001
Reexploration for bleeding 2.6 1.6–4.2 <0.0001
Mechanical ventilation > 48 hours 4.6 3.0–7.0 <0.0001
Body mass index† 1.12 1.1–1.2 <0.0001
Left ventricular ejection fraction† 0.9 0.8–0.92 <0.0001
*Defined as a 50-μmol/L absolute rise in baseline serum creatinine or a new
need for dialysis.
†Submitted to the model as continuous variables.
CI confidence interval, CPB cardiopulmonary bypass.
Figure 1 Survival among BIMA patients comparing: A) Non-insulin dep
developed DSWI versus those who did not; C) Patients with BMI > 30 kg
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of the right versus the left IMA to bypass the LAD, fe-
male gender, BMI, and non-insulin dependent diabetes
were not associated with long-term mortality among
BIMA patients in this model. Analysis stratified by age
shows that survival benefit is lost after 65 years of age,
and that there may be a survival detriment associated
with BIMA at age 80 (Table 6).
Discussion
Several findings in this study are worthy of note. First, a
very low operative mortality (1%) was observed in this
contemporary, real-world cohort of BIMA patients.
These data are consistent with a recent randomized trial
examining BIMA vs. single IMA which reported a 30-
day mortality of 1.2% [6]. Second, the choice of target
for the second (non-LAD) IMA did not influence late
survival. Previous reports had suggested that the patency
of the right IMA may be lower if placed to the RCA ter-
ritory due to size discrepancy and competitive flow [7,8].
More recent data from the Cleveland Clinic group [9]
and others [10] have shown that the right IMA could be
placed to left-sided coronaries or, alternatively, RCAendent diabetes and patients without diabetes; B) Patients who
/m2 versus patients with BMI ≤ 30 kg/m2; D) Female versus male.
Figure 2 Survival among BIMA patients based on A) Site of
anastomosis of the second (non-LAD) IMA; B) Use of the left
versus right IMA to revascularize the LAD.
Table 6 Hazard ratios of late mortality according to age
among BIMA patients
Age (years) Hazard Ratio (95% CI) P- value
50 0.64 (0.51-0.82) 0.0003
55 0.70 (0.58-0.84) 0.0001
60 0.76 (0.65-0.89) 0.0007
65 0.82 (0.68-0.99) 0.0412
66 0.83 (0.69-1.01) 0.0759
67 0.85 (0.6-1.04) 0.1272
68 0.86 (0.6-1.07) 0.1953
69 0.88 (0.70-1.10) 0.2779
70 0.89 (0.70-1.14) 0.3711
75 0.97 (0.70-1.56) 0.8550
80 1.05 (0.70-1.56) 0.7978
For clarity, age categories are shown at 5-year intervals except between the
ages of 65 and 70 where they are shown per annum, in order to determine
the age between 65 and 70 years at which the benefit of BIMA is no longer
statistically significant. This occurs at 66 years of age.
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though we observed a trend to an improved unadjusted
survival among BIMA patients in which the LIMA was
grafted to the LAD compared to those in which the RIMA
was grafted to the LAD (log-rank p = 0.06, Figure 2B), this
factor was not predictive of late survival in the Cox multi-
variate model.
Another relevant finding from our data is that the use
of insulin was the major driver behind the survival dis-
advantage of diabetes in patients undergoing BIMA,
such that there was no difference in survival among dia-
betics who were not receiving chronic outpatient insulin
therapy and those without diabetes (Figure 1A). Looking
at the data from Table 2, we see that there a very few
clinically relevant differences between the patients with
diabetes not treated with insulin receiving BIMA and
those without diabetes receiving BIMA which may ex-
plain the equivalent survival outcome. The contribution
of diabetes to adverse events and mortality following
BIMA grafting remains controversial with conflicting re-
sults in the literature [11-14]. However, our data suggest
that diabetes in the absence of insulin therapy should
not deter a surgeon from pursuing a BIMA revasculari-
zation strategy.
The fear of sternal devascularisation and infection is a
major limitation in the widespread use of BIMA. How-
ever, recent advances in the management of DSWI have
lessened its impact on CABG outcomes [13]. The role of
diabetes as a major risk factor for DSWI has been exten-
sively studied. The prevalence of diabetes was three
times higher among patients with DSWI versus those
without DSWI in our series which is consistent with ob-
servations in the Arterial Revascularisation Trial (ART)
[6]. In an earlier report, Cosgrove et al. [14] studied the
risk of BIMA grafting and identified diabetes and ad-
vanced age, but not BIMA grafting itself, as risk factors
for wound complications. Although the incidence of
DSWI after BIMA grafting is relatively low in most
series, the morbidity and cost associated with sternal in-
fection are significant [12,15]. This increase in the risk
of sternal infection in diabetic patients has to be bal-
anced against the fact that diabetic patients may actually
have the most to gain from BIMA grafting [16,17]. Our
data show that, excluding diabetics treated with insulin,
diabetic BIMA patients had a significantly better survival
compared to single IMA patients. The presence of end-
organ compromise related to diabetes, associated risk
factors, and IMA harvesting technique should be taken
into consideration for surgical decision-making [18].
The risk of DSWI may be minimized with careful patient
selection and modification of the IMA harvesting tech-
nique, particularly in diabetic patients. Furthermore, in
our study, diabetes was not an independent predictor of
late death after BIMA grafting. A recent report by our
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CABG was not adversely affected by the presence of
non-insulin-dependent diabetes. These findings suggest
that long-term survival of diabetic patients after CABG
may be mainly related to the presence of diabetes co-
morbidities, namely peripheral vascular disease, renal
failure, low ejection fraction, and insulin dependency.
Stevens et al. [17] have shown that BIMA use in diabetic
patients improves survival and decreases the risk of cor-
onary reoperation compared with single IMA grafting.
Another finding worthy of note is that female gender,
patients with high BMI, and history of smoking did not
negatively influence long-term survival after BIMA graft-
ing in our study. The finding of a lack of association be-
tween BMI and survival according to grafting strategy
may reflect a lack of sufficient power in our study to de-
tect a difference, given the fact that BMI was extremely
similar among the 2 groups (Table 1) and very obese pa-
tients (BMI > 40) were conspicuously absent from the
BIMA group. Earlier studies have shown that female
gender is an independent risk factor for in-hospital and
long-term mortality after CABG. It has been also sug-
gested that women derive less benefit from BIMA graft-
ing. However, recent reports [20,21] have not validated
these data, and women appear to benefit from BIMA
grafting as much as men.
Limitations
This study has some inherent limitations. It was per-
formed in a non-randomized manner in a single referral
center. Also, our analysis does not account for the time-
dependent nature of certain patient characteristics, such
as ejection fraction and diabetes, which are prognostic-
ally important and may change over time. The preven-
tion of graft disease has evolved with the introduction of
new drug therapies during follow-up, but we expect
these new treatments to have been equally distributed
among the groups we studied. Our data suggest that the
late survival benefit appears to be lost after the age of 65
for patients undergoing BIMA grafts. It is not unreason-
able to expect that these patients may continue to ex-
perience sustained improvements in anginal status and
quality of life owing to better long-term patency of arter-
ial grafts; however, these variables were not specifically
assessed in this study. We excluded free IMA grafts and
alternative arterial conduits such as the radial artery
from our analysis in order to increase the homogeneity
of the studied patients and allow for meaningful multi-
variate analyses within this patient subgroup.
Conclusion
An in-situ BIMA grafting strategy should not be with-
held from patients according to sex, BMI, and from
those with diabetes mellitus. However, advanced age,COPD, and patients with insulin-treated diabetes melli-
tus may not benefit from BIMA grafts. The right and left
IMAs are equally effective conduits for the LAD, and
the non-LAD coronary artery territory grafted by the
second IMA did not influence outcome.
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